3D SYSTEMS CORP: management transactions · United States · SEC (Form 4)

About 3D SYSTEMS CORP

3D Systems Corp. (ticker DDD) is a U.S.-based technology company listed on the NYSE in the United States and widely regarded as one of the pioneers of 3D printing and additive manufacturing. The company traces its origins to the work of Chuck Hull, the inventor of stereolithography, and was built into a commercial platform from its headquarters in Rock Hill, South Carolina. Over time, 3D Systems has developed an application-led business model spanning hardware, materials, software, and related services, with a focus on high-value manufacturing and healthcare use cases. Today, the company’s operations are organized around two core segments: Healthcare Solutions and Industrial Solutions. Healthcare Solutions includes dental, medical device, personalized health services, and regenerative medicine activities, while Industrial Solutions covers aerospace, defense, transportation, and general manufacturing applications. This structure gives the company a broader exposure than a pure equipment vendor, combining recurring consumables and services with system sales. At the same time, customer capital spending cycles remain an important variable for revenue and profitability. 3D Systems occupies a historically important position in the additive manufacturing industry. It competes with other established players such as Stratasys, EOS, Materialise, and a range of specialized industrial printing companies. Its competitive advantage comes from being an early mover, maintaining a sizable installed base, and offering an integrated stack of printers, materials, and software. Key product families include stereolithography (SLA) systems, polymer and metal printing solutions, proprietary materials, and workflow software designed to help customers move from digital design to production. Recent company updates show a continued strategic emphasis on the most attractive end markets. In 2025, 3D Systems announced the full commercial release of its FDA-cleared NextDent Jetted Denture Solution for the U.S. market, reinforcing its digital dentistry portfolio. The company also introduced next-generation SLA solutions and highlighted efficiency gains from its cost-reduction programs. In its first-quarter 2026 results, 3D Systems said performance improved in Healthcare, Dental, Med Tech, and Aerospace & Defense. For investors, DDD remains a cyclical growth-tech name with long-term exposure to industrial digitization, medical innovation, and the broader adoption of additive manufacturing across mission-critical applications.